UniProt ID | TAF9B_HUMAN | |
---|---|---|
UniProt AC | Q9HBM6 | |
Protein Name | Transcription initiation factor TFIID subunit 9B | |
Gene Name | TAF9B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 251 | |
Subcellular Localization | Nucleus. | |
Protein Description | Essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription factor IID (TFIID) complex, the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TFIID or TFTC are essential for the regulation of RNA polymerase II-mediated transcription.. | |
Protein Sequence | MESGKMAPPKNAPRDALVMAQILKDMGITEYEPRVINQMLEFAFRYVTTILDDAKIYSSHAKKPNVDADDVRLAIQCRADQSFTSPPPRDFLLDIARQKNQTPLPLIKPYAGPRLPPDRYCLTAPNYRLKSLIKKGPNQGRLVPRLSVGAVSSKPTTPTIATPQTVSVPNKVATPMSVTSQRFTVQIPPSQSTPVKPVPATTAVQNVLINPSMIGPKNILITTNMVSSQNTANEANPLKRKHEDDDDNDIM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MESGKMAP -------CCCCCCCC | 9.26 | 22814378 | |
3 | Phosphorylation | -----MESGKMAPPK -----CCCCCCCCCC | 42.27 | 20860994 | |
5 | Ubiquitination | ---MESGKMAPPKNA ---CCCCCCCCCCCC | 40.96 | 22505724 | |
5 | Acetylation | ---MESGKMAPPKNA ---CCCCCCCCCCCC | 40.96 | 25953088 | |
10 | Ubiquitination | SGKMAPPKNAPRDAL CCCCCCCCCCCHHHH | 65.76 | - | |
24 | Ubiquitination | LVMAQILKDMGITEY HHHHHHHHHCCCCCC | 47.50 | 22817900 | |
46 | Phosphorylation | MLEFAFRYVTTILDD HHHHHHHHHHHHHHH | 8.83 | 29083192 | |
48 | Phosphorylation | EFAFRYVTTILDDAK HHHHHHHHHHHHHHH | 10.13 | 29083192 | |
49 | Phosphorylation | FAFRYVTTILDDAKI HHHHHHHHHHHHHHH | 14.97 | 29083192 | |
55 | Ubiquitination | TTILDDAKIYSSHAK HHHHHHHHHHHCCCC | 49.52 | - | |
57 | Phosphorylation | ILDDAKIYSSHAKKP HHHHHHHHHCCCCCC | 11.92 | - | |
62 | Ubiquitination | KIYSSHAKKPNVDAD HHHHCCCCCCCCCHH | 64.44 | 29967540 | |
63 | Acetylation | IYSSHAKKPNVDADD HHHCCCCCCCCCHHH | 42.48 | 26051181 | |
63 | Ubiquitination | IYSSHAKKPNVDADD HHHCCCCCCCCCHHH | 42.48 | 29967540 | |
82 | Phosphorylation | IQCRADQSFTSPPPR HCCCCCCCCCCCCCC | 30.92 | 29396449 | |
84 | Phosphorylation | CRADQSFTSPPPRDF CCCCCCCCCCCCCHH | 45.64 | 21815630 | |
85 | Phosphorylation | RADQSFTSPPPRDFL CCCCCCCCCCCCHHH | 33.14 | 25159151 | |
99 | Ubiquitination | LLDIARQKNQTPLPL HHHHHHHCCCCCCCC | 45.53 | - | |
102 | Phosphorylation | IARQKNQTPLPLIKP HHHHCCCCCCCCCCC | 35.87 | 25159151 | |
108 | Ubiquitination | QTPLPLIKPYAGPRL CCCCCCCCCCCCCCC | 39.39 | 29967540 | |
108 | Acetylation | QTPLPLIKPYAGPRL CCCCCCCCCCCCCCC | 39.39 | 26051181 | |
119 | Methylation | GPRLPPDRYCLTAPN CCCCCCCCCEECCCC | 29.82 | - | |
128 | Methylation | CLTAPNYRLKSLIKK EECCCCHHHHHHHHH | 42.13 | 26494477 | |
131 | Phosphorylation | APNYRLKSLIKKGPN CCCHHHHHHHHHCCC | 39.66 | 24719451 | |
147 | Phosphorylation | GRLVPRLSVGAVSSK CCCCCCEEECCCCCC | 21.56 | 26055452 | |
152 | Phosphorylation | RLSVGAVSSKPTTPT CEEECCCCCCCCCCC | 31.91 | 30278072 | |
152 | O-linked_Glycosylation | RLSVGAVSSKPTTPT CEEECCCCCCCCCCC | 31.91 | 30059200 | |
153 | O-linked_Glycosylation | LSVGAVSSKPTTPTI EEECCCCCCCCCCCC | 35.74 | 30059200 | |
153 | Phosphorylation | LSVGAVSSKPTTPTI EEECCCCCCCCCCCC | 35.74 | 28355574 | |
154 | Acetylation | SVGAVSSKPTTPTIA EECCCCCCCCCCCCC | 38.59 | 26051181 | |
156 | Phosphorylation | GAVSSKPTTPTIATP CCCCCCCCCCCCCCC | 49.50 | 26055452 | |
156 | O-linked_Glycosylation | GAVSSKPTTPTIATP CCCCCCCCCCCCCCC | 49.50 | 30059200 | |
157 | O-linked_Glycosylation | AVSSKPTTPTIATPQ CCCCCCCCCCCCCCC | 27.28 | 30059200 | |
157 | Phosphorylation | AVSSKPTTPTIATPQ CCCCCCCCCCCCCCC | 27.28 | 28355574 | |
159 | O-linked_Glycosylation | SSKPTTPTIATPQTV CCCCCCCCCCCCCEE | 22.58 | 30059200 | |
159 | Phosphorylation | SSKPTTPTIATPQTV CCCCCCCCCCCCCEE | 22.58 | 22617229 | |
162 | O-linked_Glycosylation | PTTPTIATPQTVSVP CCCCCCCCCCEEECC | 16.45 | 30059200 | |
162 | Phosphorylation | PTTPTIATPQTVSVP CCCCCCCCCCEEECC | 16.45 | 26055452 | |
165 | Phosphorylation | PTIATPQTVSVPNKV CCCCCCCEEECCCCE | 18.89 | 26074081 | |
167 | O-linked_Glycosylation | IATPQTVSVPNKVAT CCCCCEEECCCCEEC | 34.93 | 30059200 | |
167 | Phosphorylation | IATPQTVSVPNKVAT CCCCCEEECCCCEEC | 34.93 | 26074081 | |
174 | Phosphorylation | SVPNKVATPMSVTSQ ECCCCEECCCEEECC | 23.63 | 25159151 | |
177 | O-linked_Glycosylation | NKVATPMSVTSQRFT CCEECCCEEECCEEE | 24.36 | 30059200 | |
177 | Phosphorylation | NKVATPMSVTSQRFT CCEECCCEEECCEEE | 24.36 | 25159151 | |
179 | Phosphorylation | VATPMSVTSQRFTVQ EECCCEEECCEEEEE | 16.31 | 20068231 | |
180 | Phosphorylation | ATPMSVTSQRFTVQI ECCCEEECCEEEEEC | 19.73 | 20068231 | |
190 | Phosphorylation | FTVQIPPSQSTPVKP EEEECCCCCCCCCCC | 31.26 | - | |
192 | Phosphorylation | VQIPPSQSTPVKPVP EECCCCCCCCCCCCC | 38.73 | - | |
193 | Phosphorylation | QIPPSQSTPVKPVPA ECCCCCCCCCCCCCC | 25.19 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF9B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF9B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF9B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRI15_HUMAN | TRIM15 | physical | 20211142 | |
A4_HUMAN | APP | physical | 21832049 | |
TRRAP_HUMAN | TRRAP | physical | 15899866 | |
TAF9B_HUMAN | TAF9B | physical | 15899866 | |
TAF1_HUMAN | TAF1 | physical | 15899866 | |
TAF5_HUMAN | TAF5 | physical | 15899866 | |
KAT2A_HUMAN | KAT2A | physical | 15899866 | |
TAF6_HUMAN | TAF6 | physical | 15899866 | |
TAF7_HUMAN | TAF7 | physical | 15899866 | |
TBP_HUMAN | TBP | physical | 15899866 | |
TAF9_HUMAN | TAF9 | physical | 15899866 | |
TAF4_HUMAN | TAF4 | physical | 26344197 | |
TAF5_HUMAN | TAF5 | physical | 26344197 | |
TAF6_HUMAN | TAF6 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-157, AND MASSSPECTROMETRY. |